Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda.

Anglewicz, Philip; Larson, Elizabeth; Akilimali, Pierre; Guiella, Georges; Kayembe, Patrick; Kibira, Simon P S; Makumbi, Fredrick; Radloff, Scott

Anglewicz, Philip; Larson, Elizabeth; Akilimali, Pierre; Guiella, Georges; Kayembe, Patrick; Kibira, Simon P S; Makumbi, Fredrick; Radloff, Scott.

Afiliação

Anglewicz P; Johns Hopkins Bloomberg School of Public Health, Department of Population, Family and Reproductive Health.
Larson E; Johns Hopkins Bloomberg School of Public Health, Department of Population, Family and Reproductive Health.
Akilimali P; School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Guiella G; Institut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Kayembe P; School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Kibira SPS; Makerere University School of Public Health, Kampala, Uganda.
Makumbi F; Makerere University School of Public Health, Kampala, Uganda.
Radloff S; Johns Hopkins Bloomberg School of Public Health, Department of Population, Family and Reproductive Health.

Contracept X ; 3: 100055, 2021.

Article em En | MEDLINE | ID: mdl-33554107

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Contracept X Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google